hypoxia inducible factor prolyl hydroxylase domain inhibitors (CrystalGenomics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehypoxia inducible factor prolyl hydroxylase domain inhibitors (CrystalGenomics)
Drug Alias NameDN-200496DN-200660
ClassificationSmall molecules
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitorsHaematopoiesis stimulants
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrystalgenomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrystalgenomics Inc
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A